PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 253 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $229,000 | -6.9% | 5,615 | -11.9% | 0.01% | 0.0% |
| Q4 2022 | $246,000 | -28.3% | 6,371 | -1.2% | 0.01% | -40.0% |
| Q3 2022 | $343,000 | +6.9% | 6,446 | +17.2% | 0.02% | +15.4% |
| Q2 2022 | $321,000 | -26.7% | 5,502 | -4.1% | 0.01% | -13.3% |
| Q1 2022 | $438,000 | +3.8% | 5,735 | -18.1% | 0.02% | +15.4% |
| Q4 2021 | $422,000 | +6.8% | 7,006 | -0.7% | 0.01% | -7.1% |
| Q3 2021 | $395,000 | -7.3% | 7,057 | +0.6% | 0.01% | 0.0% |
| Q2 2021 | $426,000 | -15.1% | 7,016 | -2.1% | 0.01% | -17.6% |
| Q1 2021 | $502,000 | +15.1% | 7,166 | -1.6% | 0.02% | +13.3% |
| Q4 2020 | $436,000 | -0.7% | 7,282 | -0.4% | 0.02% | -6.2% |
| Q3 2020 | $439,000 | +19.0% | 7,309 | +4.1% | 0.02% | +14.3% |
| Q2 2020 | $369,000 | +13.9% | 7,024 | -27.2% | 0.01% | +7.7% |
| Q1 2020 | $324,000 | – | 9,649 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |